This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
XBP1 · Western blot design guide
Design a Western Blot for XBP1
Real validated XBP1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-XBP1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Last reviewed: May 2026 · Scientific review: Boster Bio technical team
XBP1 Western Blot Experimental Design Guide
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | ~28.7 kDa | |
| Observed band | ~29 kDa | |
| Gel | 12–15% | |
| Negative control | siRNA / KO lysate |
Important caveats
Reasons your observed band may differ from the expected size.
| PTM | Phosphorylated + Acetylated | |
| Caveat | Alternative splicing isoforms | |
| Regulation | Estrogen up | |
| Isoform | 2 isoform(s) |
Section 1
Real Curated XBP1 Western Blot Protocols
Literature-validated Western blot parameters for XBP1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | MCF-7 at 40ug, Lane 2: MM231 at 40ug, Lane 3: MM453 at 40ug, Lane 4: SKOV at 40ug, Lane 5: HELA at 40ug. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-XBP antigen affinity purified polyclonal antibody (Catalog # PB9463) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for XBP at approximately 29 kDa. The expected band size for XBP is at 29 kDa |
| Gel % | 12–15% |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 29 kDa |
Section 2
What Is the Expected XBP1 Western Blot Band Size?
XBP1 has a 28.7 kDa predicted mass and runs at the closely matching ~29 kDa observed band, with minimal shift since it lacks glycosylation or disulfide bonds.
| Single sharp band near 29 kDa | Matches the 28.7 kDa predicted mass since XBP1 has no glycosylation, disulfide bonds, or signal-peptide cleavage to alter migration |
| Two bands at different apparent sizes | Reflects detection of both annotated isoforms (isoform 1 and isoform 2), which differ in sequence and therefore mass |
| Faint high-molecular-weight smear or ladder above the main band | Ubiquitinated isoform 1 generated through its RNF139 interaction and tagged for proteasomal degradation |
| Slight doublet or fuzzy edge on the main band | Phosphorylation at Ser47 and Ser68 can cause a minor mobility shift relative to the unmodified protein |
| Signal present in both membrane-enriched and nuclear fractions | Isoform 1 is anchored to the ER membrane via its signal-anchor/transmembrane region while the other isoform can access the nucleus |
💡Expected XBP1 appearanceXBP1 typically runs as a single band at approximately 29 kDa in whole-cell lysate, closely matching its 28.7 kDa predicted mass since it has no glycosylation, disulfide crosslinking, or cleaved signal peptide to shift migration.
| Predicted mass (28.7 kDa, 261 aa) | sets the baseline migration, which closely matches the ~29 kDa band actually observed |
| Splice isoforms 1 and 2 | can produce two protein species of differing size, appearing as one dominant band or two depending on which isoform predominates in the sample |
| Phosphorylation at Ser47 and Ser68 | adds minor mass and charge that can cause a slight mobility shift or fine doublet rather than a major size change |
| Ubiquitination via RNF139 interaction | targets isoform 1 for degradation, which can appear as a faint smear or ladder above the main band |
| Absence of signal peptide, glycosylation, and disulfide bonds | means no cleavage-based downshift, no glyco-smear, and no dimer band at roughly twice the monomer mass are expected |
| Situation | Likely cause | Next action |
|---|---|---|
| Multiple bands | both splice isoforms are present, or ubiquitin-conjugated isoform 1 species accumulate alongside the unmodified protein | use an isoform-specific antibody or epitope mapping to distinguish species, and compare with proteasome-inhibitor-treated lysate to confirm which bands are ubiquitinated |
| Band higher than expected | ubiquitinated isoform 1 conjugates generated through the RNF139 interaction run above the native ~29 kDa band | add a proteasome inhibitor such as MG132 during treatment and use fresh lysate to limit accumulation of modified species |
| Weak or no signal | XBP1 expression and isoform ratio depend on ER stress state, so basal levels can be low without induction | induce ER stress with thapsigargin or tunicamycin before lysis and load more total protein |
| No band in lysate | XBP1 partitions between ER membrane and nuclear compartments depending on isoform, so a cytoplasm-only extraction can miss it | use a whole-cell or RIPA-based lysis buffer that solubilizes membrane and nuclear fractions |
| Band lower than expected | proteolytic degradation during lysis of the labile protein produces smaller fragments | keep samples cold, add protease inhibitors immediately at lysis, and minimize freeze-thaw cycles |
Experiment evidence
Western blot images showing XBP1 band
PB9463 · XBP1
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for XBP1 Western blot
🧪For positive controls for XBP1 in Western blot, you can use VEGF-stimulated endothelial cells, since UniProt evidence shows XBP1 colocalizes with ERN1 and KDR in the endoplasmic reticulum specifically in this VEGF-dependent context.
Positive control: VEGF-stimulated endothelial cells
Negative control: ubiquitously expressed; use siRNA knockdown or KO line
Loading controls: Run GAPDH and β-actin alongside a total-protein stain (e.g., stain-free gel, Ponceau S, or REVERT) as loading controls.
⚠️Feasibility: No HPA tissue expression data is available and XBP1 is an ER-resident transcription factor whose detection depends on stimulus (e.g., VEGF or ER stress), so a clean basal positive/negative tissue pair is hard to establish and stress-induction or genetic controls are recommended instead.
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Section 3
Advanced XBP1 Western Blot Tips
Deeper troubleshooting and optimisation questions for XBP1, answered from its protein features.
Why does XBP1 run close to its predicted 28.7 kDa mass?
XBP1 has no glycosylation sites and no disulfide bonds, so its unspliced isoform migrates near its calculated mass of 28.7 kDa, consistent with the ~29 kDa band typically observed. Any minor discrepancy from predicted mass likely reflects its two annotated modified residues (acetylation/phosphorylation) rather than glycosylation or disulfide-driven shifts.
Why might I see two different XBP1 bands?
XBP1 has two annotated isoforms arising from alternative splicing, and it colocalizes with ERN1 (IRE1) in the ER, consistent with IRE1-driven splicing regulating isoform production. Blots may show two distinct XBP1 species; confirm which isoform your antibody's epitope targets before interpreting differences in band position or intensity.
Does ER stress affect XBP1 protein levels or modification?
Yes. XBP1 is annotated for stress response and unfolded protein response, and is a phosphoprotein with two modified residues. ER-stress-inducing treatments are expected to alter its splicing status, abundance, and modification state, so include an ER-stress-induced condition alongside untreated samples as a positive control for detecting these changes.
How should I optimize blocking for XBP1 detection?
XBP1 is a single-pass membrane protein with a signal-anchor transmembrane helix, which can increase nonspecific background on blotting membranes. Use 5% non-fat milk or BSA in TBST with an extended blocking time, and include 0.1% Tween-20 in wash buffers to minimize hydrophobic background around the ~29 kDa region.
What transfer method to use for XBP1 Western blot?
Because XBP1 contains a transmembrane signal-anchor helix, standard wet transfer with a methanol-containing buffer (10-20%) is recommended over semi-dry transfer to ensure efficient elution of this membrane-associated, ER-localized protein from the gel, particularly for isoform 1, which resides at the ER membrane.
How should I quantify XBP1 induction across samples?
Since XBP1 is stress-inducible and undergoes alternative splicing, quantify signal per isoform band rather than a single combined intensity, and normalize to a stable loading control. Because isoform 1 is also targeted for ubiquitin-mediated degradation via RNF139, changes in total signal may reflect altered turnover rather than induction alone.
What explains higher molecular weight XBP1 bands?
XBP1 isoform 1 interacts with RNF139, which ubiquitinates it and promotes its degradation; this ubiquitin conjugation can produce a ladder or smear of higher-molecular-weight bands above the ~29 kDa main band. XBP1 is also cleaved at a pair of basic residues, which may generate additional lower-molecular-weight fragments on some blots.
Boster reagents
Best XBP1 Western Blot Antibodies
BosterBio's XBP1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Real WB data
Anti-XBP1 Antibody Picoband®
Cat # PB9463
For XBP1 Western blotting, we highlight the Boster antibody with a documented, published-style WB result, giving you a concrete reference image to gauge expected banding before you run your own blot.
Which to pick: Only one XBP1 antibody is catalogued here, PB9463, which includes a WB validation image (MCF-7 whole cell lysate, 5-20% SDS-PAGE). Use it as your default choice and confirm reactivity in your own sample type.
Source: BosterBio XBP1 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.
References
- UniProt Consortium. UniProt entry P17861.
- Human Protein Atlas. XBP1 tissue expression.